✦ LIBER ✦

Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Age 60-70 Years with Acute Myelogenous Leukemia in First Remission

✍ Scribed by Sherif S. Farag; Kati Maharry; Mei-Jie Zhang; Waleska S. Pérez; Stephen L. George; Krzysztof Mrózek; John DiPersio; Donald W. Bunjes; Guido Marcucci; Maria R. Baer; Mitchell Cairo; Edward Copelan; Corey S. Cutler; Luis Isola; Hillard M. Lazarus; Mark R. Litzow; David I. Marks; Olle Ringdén; David A. Rizzieri; Robert Soiffer; Richard A. Larson; Martin S. Tallman; Clara D. Bloomfield; Daniel J. Weisdorf

Book ID: 116282697
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 298 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.06.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Allogeneic Hematopoietic C

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission

✍ Saiko Kurosawa; Takuhiro Yamaguchi; Naoyuki Uchida; Shuichi Miyawaki; Kensuke Us 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 778 KB

Allogeneic Hematopoietic Cell Transplant

Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine

✍ Platzbecker, Uwe; Schetelig, Johannes; Finke, Jürgen; Trenschel, Rudolf; Scott, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 272 KB

144Outcome of hematopoietic progenitor c

144Outcome of hematopoietic progenitor cells transplant in patients with acute myelogenous leukemia in first complete remission report form a single institution

✍ G.A. Milone; J. Martinez Rolon; I.I. Fernandez; C.S. Corrado; S. Pavlovsky; M. J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 147 KB

356: First line sequential therapy with

356: First line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic stem cell transplantation (ASCT) after reduced intensity conditioning (RIC) for patients with acute myeloblastic leukemia (AML) in first complete remission (CR1)

✍ D. Blaise; R. Tabrizi; C. Faucher; M. Mohty; J.O. Bay; J.M. Boiron; G. Marit; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Hematopoietic cell transplantation from

Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission

✍ Frederick R. Appelbaum 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Benefit of Allogeneic Transplantation in

Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years with Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant

✍ Michelis, Fotios V.; Messner, Hans A.; Atenafu, Eshetu G.; Kim, Dennis D.; Kuruv 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 391 KB